SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042650
Filing Date
2021-08-09
Accepted
2021-08-09 16:16:42
Documents
63
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rna-10q_20210630.htm   iXBRL 10-Q 1892396
2 EX-31.1 rna-ex311_6.htm EX-31.1 10271
3 EX-31.2 rna-ex312_8.htm EX-31.2 10246
4 EX-32.1 rna-ex321_9.htm EX-32.1 6781
5 EX-32.2 rna-ex322_7.htm EX-32.2 6754
  Complete submission text file 0001564590-21-042650.txt   7074953

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rna-20210630.xsd EX-101.SCH 57360
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rna-20210630_cal.xml EX-101.CAL 46108
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rna-20210630_def.xml EX-101.DEF 187741
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20210630_lab.xml EX-101.LAB 451388
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20210630_pre.xml EX-101.PRE 338743
11 EXTRACTED XBRL INSTANCE DOCUMENT rna-10q_20210630_htm.xml XML 1145797
Mailing Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037
Business Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39321 | Film No.: 211156704
SIC: 2834 Pharmaceutical Preparations